Myeloma Study Days 29th June & 5th July 2017

For the last two years BOPA has successfully worked alongside Amgen to deliver Myeloma study days featuring the excellent Elaine Vickers who can really bring the science of novel agents life, the day will also feature clinical updates from leading local clinicians.  
 
The good news is the event organisers, Amgen, are able to make the days free for BOPA members.  It’s also worth noting that the study days are non-promotional educational events so the speakers will be covering all new drug developments in myeloma.  The feedback from last year’s events was excellent so it’s definitely one for the diary.

Look out for emails with details of how to register for the Sheffield study day on 29th June 2017 and the London study day on 5th July 2017.

Steve Williamson, BOPA chair

Latest News

By NHS Infusions and Special Medicines Programme on 4th September 2026

Expressions of interest for Expert Panel Sub Group to support the approval and implementation of Standardised Product Specifications

Expressions of interest for Expert Panel Sub Group to support the approval and implementation of Standardised Product Specifications The Infusions and Special Medicines Programme is inviting expressions of interest for…

Read article
By BOPA on 31st August 2026

🌟 BOPA Advanced Pharmacist Study Day – Elevate Your Practice, Shape Your Career

Are you an oncology or haematology pharmacist with around five or more years of experience — whether Band 7 or Band 8 — and ready to take the next step…

Read article
By BOPA Executive Committee on 31st August 2026

BOPA 2026 Executive Committee Election – One week left to cast your vote

One week left to cast your vote for the BOPA Executive Committee Election. Have your say at BOPA’s future.   In 2026 we received 9 nominations for 6 positions. -Standard…

Read article
By BOPA Executive Committee on 27th August 2026

UK multidisciplinary Consensus Document – Safe Management of Hazardous Medicinal Products in UK Healthcare Settings

We are pleased to jointly publish the new UK multidisciplinary consensus document, Safe Management of Hazardous Medicinal Products in UK Healthcare Settings. Hazardous medicinal products (HMPs) are used across a…

Read article